Tscan Therapeutics Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$2,511	$3,076	$2,171	$665
Gross Profit	1,744	3,076	2,171	665
EBITDA	-34,244	-35,565	-32,770	-34,314
EBIT	-35,011	-36,263	-33,448	-35,025
Net Income	-35,710	-36,952	-34,127	-35,809
Net Change In Cash	2,511	3,076	2,171	665
Free Cash Flow	-33,889	-34,546	-39,118	-28,300
Cash	169,506	169,394	154,108	178,689
Basic Shares	129,835	129,730	129,678	120,789

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,816	$21,049	$13,535	$10,141
Gross Profit	2,816	21,049	13,535	10,141
EBITDA	-119,738	-80,098	-59,908	-45,297
EBIT	-123,846	-85,459	-65,045	-48,625
Net Income	-127,499	-89,218	-66,221	-48,625
Net Change In Cash	2,816	21,049	13,535	10,141
Cost of Revenue			-41,372	131,050
Free Cash Flow	-114,647	-64,504	-70,728	-58,618
Cash	178,689	133,359	120,027	161,405
Basic Shares	111,990	65,599	24,048	23,907